Literature DB >> 12783434

Lack of association between the BDNF Val66Met polymorphism and Parkinson's disease in a Swedish population.

Anna Håkansson, Jonas Melke, Lars Westberg, Haydeh Niazi Shahabi, Silva Buervenich, Andrea Carmine, Kjell Klingborg, Maj-Britt Grundell, Barbara Schulhof, Björn Holmberg, Jarl Ahlberg, Elias Eriksson, Olof Sydow, Lars Olson, Bo Johnels, Hans Nissbrandt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12783434     DOI： 10.1002/ana.10585

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  9 in total

Review 1.  Challenges and promises in the development of neurotrophic factor-based therapies for Parkinson's disease.

Authors:  Tiago Martins Rodrigues; André Jerónimo-Santos; Tiago Fleming Outeiro; Ana Maria Sebastião; Maria José Diógenes
Journal:  Drugs Aging       Date:  2014-04       Impact factor: 3.923

2.  Genotyping the BDNF rs6265 (val66met) polymorphism by one-step amplified refractory mutation system PCR.

Authors:  Haroon I Sheikh; Elizabeth P Hayden; Katie R Kryski; Heather J Smith; Shiva M Singh
Journal:  Psychiatr Genet       Date:  2010-06       Impact factor: 2.458

3.  BDNF in the Aged Brain: Translational Implications for Parkinson's Disease.

Authors:  N M Mercado; T J Collier; C E Sortwell; K Steece-Collier
Journal:  Austin Neurol Neurosci       Date:  2017-09-19

Review 4.  Brain-derived neurotrophic factor in neurodegenerative diseases.

Authors:  Chiara Zuccato; Elena Cattaneo
Journal:  Nat Rev Neurol       Date:  2009-06       Impact factor: 42.937

5.  The BDNF Val66Met polymorphism has a gender specific influence on planning ability in Parkinson's disease.

Authors:  Thomas Foltynie; Simon G J Lewis; Terry E Goldberg; Andrew D Blackwell; Bhaskar S Kolachana; Daniel R Weinberger; Trevor W Robbins; Roger A Barker
Journal:  J Neurol       Date:  2005-03-21       Impact factor: 4.849

6.  Brain derived neurotrophic factor (BDNF) expression is regulated by microRNAs miR-26a and miR-26b allele-specific binding.

Authors:  Viviana Caputo; Lorenzo Sinibaldi; Alessia Fiorentino; Chiara Parisi; Caterina Catalanotto; Augusto Pasini; Carlo Cogoni; Antonio Pizzuti
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

7.  microPIR2: a comprehensive database for human-mouse comparative study of microRNA-promoter interactions.

Authors:  Jittima Piriyapongsa; Chaiwat Bootchai; Chumpol Ngamphiw; Sissades Tongsima
Journal:  Database (Oxford)       Date:  2014-11-25       Impact factor: 3.451

8.  The V471A polymorphism in autophagy-related gene ATG7 modifies age at onset specifically in Italian Huntington disease patients.

Authors:  Silke Metzger; Carolin Walter; Olaf Riess; Raymund A C Roos; Jørgen E Nielsen; David Craufurd; Huu Phuc Nguyen
Journal:  PLoS One       Date:  2013-07-22       Impact factor: 3.240

Review 9.  BDNF Polymorphism: A Review of Its Diagnostic and Clinical Relevance in Neurodegenerative Disorders.

Authors:  Ting Shen; Yuyi You; Chitra Joseph; Mehdi Mirzaei; Alexander Klistorner; Stuart L Graham; Vivek Gupta
Journal:  Aging Dis       Date:  2018-06-01       Impact factor: 6.745
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.